Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
PADCEV Plus KEYTRUDA Significantly Improves Survival for Certain Patients with Bladder Cancer When Given Before and After Surgery
Supplementary Documents (Q1 YTD/FY2025)
[Summary]Financial Results (Q1 YTD/FY2025)
Presentation Material for Information Meeting (Q1 YTD/FY2025)
Astellas Pharma, Apr-Jun (1Q) Net Income Increases by 82%
Corporate Governance Report
Sales of IZERVA (Preliminary Figures)
Notice Regarding Continuation of the Performance-linked Stock Compensation Scheme
Notice Regarding Continuation of the Performance-linked Stock Compensation Scheme and Performance-linked Stock Delivery Scheme for the Executives
Notice of Nominees for Directors
Notice Regarding Change in fair value of contingent consideration and Differences Between Consolidated Financial Forecasts and Actual Results
Presentation Material for Information Meeting (FY2024)
Supplementary Documents (FY2024)
Financial Results (FY2024)
Astellas Pharma, Last Fiscal Year's Net Income Unexpectedly Increases, 2.6 times Increase in Net Income for The Current Fiscal Year, Dividend Raised by 4 yen
Presentation Material for Sustainability Meeting (FY2024)
U.S. FDA Approves Expanded Label for Astellas’ IZERVAY(avacincaptad pegol intravitreal solution) for Geographic Atrophy
Recording of Extraordinary Losses in Non-consolidated Financial Results(J-GAAP)
Presentation Material for Information Meeting (Q3 YTD/FY2024)
Supplementary Documents (Q3 YTD/FY2024)